製品名:ethyl 2-((2-aminothiazol-5-yl)thio)acetate

IUPAC Name:ethyl 2-[(2-amino-1,3-thiazol-5-yl)sulfanyl]acetate

CAS番号:859522-19-3
分子式:C7H10N2O2S2
純度:95%
カタログ番号:CM132250
分子量:218.29

包装単位 有効在庫 価格(USD) 数量
CM132250-250mg in stock ȃIJ
CM132250-1g in stock Ǫƥƿ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:859522-19-3
分子式:C7H10N2O2S2
融点:-
SMILESコード:O=C(OCC)CSC1=CN=C(N)S1
密度:
カタログ番号:CM132250
分子量:218.29
沸点:368.9°C at 760 mmHg
MDL番号:
保管方法:Keep in dark place, store at 2-8°C.

Category Infos

Thiazoles
Thiazoles are very important functional groups in medicinal chemistry. They act as ligands on a variety of biological matrices. Thiazoles are used in a wide range of therapeutic applications, such as antibacterial, antiretroviral, antifungal, antiallergic, antihypertensive, pain treatment, and to control symptoms of schizophrenia.

Column Infos

Cadisegliatin
vTv Therapeutics announces FDA submission for first phase 3 study of Cadisegliatin in patients with type 1 diabetes. Cadisegliatin (TTP399) is developed as an adjunctive therapy to insulin for the treatment of type 1 diabetes, and the phase 3 trial evaluates its safety and efficacy.
Glucokinase (GK) is mainly concentrated in liver cells, and involved in the regulation of glucose metabolism. Cadisegliatin (TTP399) is a liver-selective glucosekinase activator with a mechanism of action different from that of antidiabetic drugs. It binds to the allosteric site of GK and restores innate glucose-regulating capacity of the liver, not disrupting the interaction between GK and GKRP. Cadisegliatin previously received a Breakthrough Therapy designation from the U.S. FDA.

Related Products